NP-01

Neuropsychiatric Disorders

  • Mental Health Disorder 01
  • More information coming soon

NP-01

  • Psychedelic inspired molecules based formulation
  • Early discovery stage project
  • Active compound selection process is ongoing
  • IP development is ongoing
  • Animal experimental model development is ongoing

CLINICAL PATH

  • Preclinical POC validation study design (ongoing)
  • In-vivo study design and preparation (ongoing)
  • Development project aimed at FDA drug candidate track